94 related articles for article (PubMed ID: 12870023)
1. [Preliminary study of HPV16 L1/E6-E7 chimeric recombinant DNA vaccine plasmid construction and expression in CHO cell].
Zheng J; Zhang FP; Si LS; Dong XP; Wang YL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):66-9. PubMed ID: 12870023
[TBL] [Abstract][Full Text] [Related]
2. Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection.
Cheung YK; Cheng SC; Sin FW; Xie Y
Vaccine; 2004 Dec; 23(5):629-38. PubMed ID: 15542183
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses.
Park DS; Selvey LA; Kelsall SR; Frazer IH
J Virol Methods; 1993 Dec; 45(3):303-18. PubMed ID: 8106603
[TBL] [Abstract][Full Text] [Related]
4. [Transformation activity and antigenicity of the human papillomavirus type 58 E6E7 fusion gene mutant].
Wang H; Yu JY; Li L
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):491-6. PubMed ID: 24257298
[TBL] [Abstract][Full Text] [Related]
5. [Construction and identification of non-replication recombinant vaccinia virus co-expressing human papillomavirus type 16 L1/L2/E6/E7 proteins].
Huang W; Tian HW; Ren J; Fan JT; Zhao L; Bian T; Lu ZH; Ruan L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):240-3. PubMed ID: 16261206
[TBL] [Abstract][Full Text] [Related]
6. Efficiency of HPV 16 L1/E7 DNA immunization: influence of cellular localization and capsid assembly.
Kuck D; Leder C; Kern A; Müller M; Piuko K; Gissmann L; Kleinschmidt JA
Vaccine; 2006 Apr; 24(15):2952-65. PubMed ID: 16414157
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1.
Lasaro MO; Diniz MO; Reyes-Sandoval A; Ertl HC; Ferreira LC
Microbes Infect; 2005 Dec; 7(15):1541-50. PubMed ID: 16213178
[TBL] [Abstract][Full Text] [Related]
8. [Expression of the human papillomavirus type 16L/E7 fusion protein in E. coli and observation of its immunogenicity in mice].
Tian HW; Ye ZM; Lu ZH; Jao R; Bian T; Zhao L; Ruan L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):33-7. PubMed ID: 16816859
[TBL] [Abstract][Full Text] [Related]
9. Prime-boost therapeutic vaccination in mice with DNA/DNA or DNA/Fowlpox virus recombinants expressing the Human Papilloma Virus type 16 E6 and E7 mutated proteins fused to the coat protein of Potato virus X.
Illiano E; Bissa M; Paolini F; Zanotto C; De Giuli Morghen C; Franconi R; Radaelli A; Venuti A
Virus Res; 2016 Oct; 225():82-90. PubMed ID: 27664839
[TBL] [Abstract][Full Text] [Related]
10. A DNA vaccine constructed with human papillomavirus type 16 (HPV16) E7 and E6 genes induced specific immune responses.
Yan Q; Cheung YK; Cheng SC; Wang XH; Shi M; Hu MH; Yong X
Gynecol Oncol; 2007 Jan; 104(1):199-206. PubMed ID: 17049969
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccine encoding heat shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens.
Huang CY; Chen CA; Lee CN; Chang MC; Su YN; Lin YC; Hsieh CY; Cheng WF
Gynecol Oncol; 2007 Dec; 107(3):404-12. PubMed ID: 17905417
[TBL] [Abstract][Full Text] [Related]
12. [Construction of recombinant vaccina virus of HPV16 and its antitumor effect].
Huang W; Tian HW; Ren J; Fan JT; Zhao L; Ruan L
Ai Zheng; 2005 Jul; 24(7):817-22. PubMed ID: 16004807
[TBL] [Abstract][Full Text] [Related]
13. Enhanced immunogenicity of human papillomavirus 16 L1 genetic vaccines fused to an ER-targeting secretory signal peptide and RANTES.
Kim SJ; Lee C; Lee SY; Kim I; Park JS; Sasagawa T; Ko JJ; Park SE; Oh YK
Gene Ther; 2003 Aug; 10(15):1268-73. PubMed ID: 12858192
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccine against oncogenic hamster cells transformed by HPV16 E6/E7 oncogenes and the activated ras oncogene.
Smahel M; Sobotkova E; Vonka V; Hamsikova E; Zak R; Kitasato H; Ludvikova V
Oncol Rep; 1999; 6(1):211-5. PubMed ID: 9864430
[TBL] [Abstract][Full Text] [Related]
15. Expression of human papillomavirus type 16 L1 protein in transgenic tobacco plants.
Liu HL; Li WS; Lei T; Zheng J; Zhang Z; Yan XF; Wang ZZ; Wang YL; Si LS
Acta Biochim Biophys Sin (Shanghai); 2005 Mar; 37(3):153-8. PubMed ID: 15756416
[TBL] [Abstract][Full Text] [Related]
16. Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6.
Peng S; Ji H; Trimble C; He L; Tsai YC; Yeatermeyer J; Boyd DA; Hung CF; Wu TC
J Virol; 2004 Aug; 78(16):8468-76. PubMed ID: 15280455
[TBL] [Abstract][Full Text] [Related]
17. Expression of HPV16 E6 or E7 increases integration of foreign DNA.
Kessis TD; Connolly DC; Hedrick L; Cho KR
Oncogene; 1996 Jul; 13(2):427-31. PubMed ID: 8710383
[TBL] [Abstract][Full Text] [Related]
18. Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells.
Smahel M; Síma P; Ludvíková V; Vonka V
Virology; 2001 Mar; 281(2):231-8. PubMed ID: 11277695
[TBL] [Abstract][Full Text] [Related]
19. Rational design of DNA vaccines for the induction of human papillomavirus type 16 E6- and E7-specific cytotoxic T-cell responses.
Oosterhuis K; Aleyd E; Vrijland K; Schumacher TN; Haanen JB
Hum Gene Ther; 2012 Dec; 23(12):1301-12. PubMed ID: 22971245
[TBL] [Abstract][Full Text] [Related]
20. Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7.
Daemen T; Riezebos-Brilman A; Bungener L; Regts J; Dontje B; Wilschut J
Vaccine; 2003 Mar; 21(11-12):1082-8. PubMed ID: 12559783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
